Rediff
Home Mail
NewsBusinessMoviesCricketSportsGetahead
Money HomeNewsForexIndicesMutual FundsInsuranceGainersLosers
TrendsStar PortfoliosMy PortfolioMy Watchlist
BusinessEmailGurusTV
News >
Headlines Defence Images Columns Interviews Specials Coverage Videos Archives
Business >
Headlines Columns Specials Personal Finance Interviews Images Technology Auto Union Budget 2026 Archives
Movies >
Headlines Images Interviews Reviews Web Series Videos South Cinema Quiz Hollywood Archives
Cricket >
Headlines Images Stats Women's T20 WC 2026 WT20 2026: Games, Players, Teams IPL 2026 Archives
Sports >
Headlines Formula 1 Football Tennis Chess Hockey
Get Ahead >
Headlines Specials Careers Glamour Health Achievers Finance Travel Food Videos Gadgets Biking Relationships Archives
Money >
News Forex Indices Sectors Mutual Funds Insurance Gainers Losers Trends Star Portfolios My Portfolio My Watchlist
More
Mail Business Email Gurus TV Rediff Podcast
Top StoriesNewsBusinessCricketMoviesSportsGet ahead
  • Headlines
  • Defence
  • Images
  • Columns
  • Interviews
  • Specials
  • Archives

News for 'drug money'

Digital arrest: Retired banker duped of Rs 23 crore

Digital arrest: Retired banker duped of Rs 23 crore

Rediff.com22 Sep 2025

Cyber fraudsters posing as ED and CBI officials duped a retired banker in Delhi of Rs 23 crore by allegedly putting him under 'digital arrest' for nearly a month.

Tylenol row may not hit India's pharma exports

Tylenol row may not hit India's pharma exports

Rediff.com29 Sep 2025

Amid controversy over USPresident Donald Trump's comments linking the use of Tylenol and other related paracetamol products by pregnant women to autism in children, experts and industry executives say that since India's export of the drug to the US is less, it will hardly affect the country's pharma exports to America.

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

ED probes money laundering in drug case linked to DMK ex-functionary

ED probes money laundering in drug case linked to DMK ex-functionary

Rediff.com10 Mar 2024

The ED will probe if money earned from the illicit narcotics trade was laundered to create movable and immovable assets by the accused. The investigation will run parallel to the NCB probe, the sources said.

Samvat 2082: Investors likely to see up to 15% returns from equities

Samvat 2082: Investors likely to see up to 15% returns from equities

Rediff.com5 Nov 2025

After a year of modest returns, equity investors may anticipate gains of 10-15 per cent in Samvat 2082, which began on October 21. Although valuations have moderated from their peaks a year earlier, they remain above long-term averages, potentially limiting sharp upsides.

'Goa Nightclub Fire Was Murder!'

'Goa Nightclub Fire Was Murder!'

Rediff.com9 Dec 2025

'When an establishment operates despite demolition or closure orders, without proper fire exits, evacuation plans or safety audits, and yet is allowed to host large crowds, the state cannot hide behind the language of accident.' 'The authorities were aware of the risks and of the violations, but chose not to act decisively because doing so would have inconvenienced those with influence and financial stakes.' 'In such a scenario, the moral and legal responsibility for the resulting deaths moves from negligence towards culpability; calling it 'murder' is a way of underlining that these lives were sacrificed at the altar of greed and complicity, not fate.'

Mankind taps OpenAI to institutionalise AI in ops

Mankind taps OpenAI to institutionalise AI in ops

Rediff.com18 Sep 2025

Delhi-based pharma major Mankind Pharma on Wednesday announced a collaboration with OpenAI to institutionalise artificial intelligence (AI) across its value chain, making it one of the first few Indian pharmaceutical companies to fully integrate advanced AI into its core operations.

Pharma stocks slide as US headwinds hurt

Pharma stocks slide as US headwinds hurt

Rediff.com16 Sep 2025

Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.

Separatist mindset dominates DMK's model of politics: Sitharaman

Separatist mindset dominates DMK's model of politics: Sitharaman

Rediff.com7 Sep 2025

Finance Minister Nirmala Sitharaman criticizes the DMK government in Tamil Nadu, alleging corruption, caste-based crimes, and a rise in drug abuse. She dismisses the DMK's claims about language and Dravidian identity as a distraction from their governance failures.

Import duties on 25 critical minerals, 36 drugs removed

Import duties on 25 critical minerals, 36 drugs removed

Rediff.com1 Feb 2025

Finance Minister Nirmala Sitharaman on Saturday announced the removal of import duties on 12 critical minerals, lithium-ion batteries scrap, cobalt products, LED, zinc and 36 drugs for cancer and rare diseases.

Tamil Nadu film producer, who was expelled by DMK, held in drugs case

Tamil Nadu film producer, who was expelled by DMK, held in drugs case

Rediff.com9 Mar 2024

The Narcotics Control Bureau (NCB) on Saturday said it has arrested Jaffer Sadiq, a Tamil Nadu-based alleged dealer of narcotics, in connection with an international drugs trafficking investigation case.

ED raids premises of Dulquer Salmaan, Prithviraj in luxury car smuggling case

ED raids premises of Dulquer Salmaan, Prithviraj in luxury car smuggling case

Rediff.com8 Oct 2025

The searches by the ED also covered certain vehicle owners, auto workshops, and traders in Ernakulam, Thrissur, Kozhikode, Malappuram, Kottayam and Coimbatore (Tamil Nadu).

India's Space Manufacturing Boom

India's Space Manufacturing Boom

Rediff.com15 Aug 2025

The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033.

Pharma cos may see short-term price blip: Ind-Ra

Pharma cos may see short-term price blip: Ind-Ra

Rediff.com27 Aug 2025

Any potential tariffs on pharmaceutical imports into the US are unlikely to impact the credit profiles of Indian firms except for a short-term pricing blip, according to a report by India Ratings and Research (Ind-Ra). The report stated that the US generics market contributes around 35 per cent to the total revenue of the leading Indian pharma firms.

Why Trust In Ambani, Adani, India Inc Is Vital

Why Trust In Ambani, Adani, India Inc Is Vital

Rediff.com12 Sep 2025

Who else will take on the might of Microsoft, Google, and Amazon if not the Adanis, Ambanis, Birlas, or Tatas?, asks R Jagannathan.

Is Your Child A Digital Addict?

Is Your Child A Digital Addict?

Rediff.com6 Oct 2025

'Parents only realise the trap in which their children fell after losing money. Some exploit children for sexual acts such as pornography and the narcotics trade.'

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

Rediff.com12 Aug 2025

If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts. This is after assuming that about 75 per cent of the tariff would be passed on.

Luxury cars with fake Army, US embassy seal seized in Kerala

Luxury cars with fake Army, US embassy seal seized in Kerala

Rediff.com24 Sep 2025

Customs officials in Kerala conducted raids across the state, seizing luxury vehicles illegally imported from Bhutan with forged documents. The operation, dubbed 'Operation Numkhor,' targeted multiple locations and uncovered a network involved in smuggling cars, gold, and drugs.

26/11 Hero Bajrang Singh's Downfall And Capture

26/11 Hero Bajrang Singh's Downfall And Capture

Rediff.com4 Oct 2025

How a Legendary Commando's Downfall Began with a Simple Meal: The Tale of Bajrang Singh's Capture.

Sheena Bora murder: Indrani's daughter denies statement, cites forgery

Sheena Bora murder: Indrani's daughter denies statement, cites forgery

Rediff.com3 Sep 2025

Vidhie Mukerjea, a key witness in the Sheena Bora murder case, denied making a statement to probe agencies, claiming documents in the CBI chargesheet were forged. She also alleged that Rahul and Rabin Mukerjea stole her mother's assets and had a motive to falsely implicate her.

Exports rise 6.7% in August, imports decline

Exports rise 6.7% in August, imports decline

Rediff.com15 Sep 2025

India's exports rose 6.7 per cent to $35.1 billion in August annually, while imports declined 10.12 per cent to $61.59 billion, according to government data released on Monday. Gold imports were down nearly 56 per cent in August, helping to trim merchandise trade deficit to $26.49 billion in August, as against $35.64 billion in the year-ago month.

Yemen cancels death sentence of Kerala nurse, claims Grand Mufti

Yemen cancels death sentence of Kerala nurse, claims Grand Mufti

Rediff.com29 Jul 2025

According to a statement issued by the Grand Mufti's office, the decision was made after a high-level meeting held in Yemen's capital, Sanaa, where it was decided to completely cancel the death sentence, which had been temporarily suspended earlier.

Can MFN Pricing Reshape India-US Pharma Equation?

Can MFN Pricing Reshape India-US Pharma Equation?

Rediff.com5 Jun 2025

US accounts for a large part of revenue for top Indian pharma companies like Gland Pharma (54 percent), Dr Reddy's (53 per cent), and Aurobindo Pharma (48 per cent).

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Rediff.com30 Jun 2025

The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025-29, a 65 per cent rise over the previous five years, according to a report by Antique stock broking limited.

Wockhardt exits US generics biz, to focus on innovation

Wockhardt exits US generics biz, to focus on innovation

Rediff.com12 Jul 2025

Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday announced a shift in its United States (US) operations. The Indian pharma giant revealed that it has decided to exit the generics pharmaceutical segment in the country.

Nothing much we can do: Govt to SC on Indian nurse's execution in Yemen

Nothing much we can do: Govt to SC on Indian nurse's execution in Yemen

Rediff.com14 Jul 2025

The Indian government is making every possible effort to save an Indian nurse facing execution in Yemen for murder, the Centre told the Supreme Court.

'Turbaned Tornado' Fauja Singh laid to rest in Jalandhar

'Turbaned Tornado' Fauja Singh laid to rest in Jalandhar

Rediff.com21 Jul 2025

The last rites of marathon legend Fauja Singh were held in Jalandhar on Sunday following his tragic death in a road accident on July 14.

Money from drugs trade returns to Pak for terror activities in J-K: DGP

Money from drugs trade returns to Pak for terror activities in J-K: DGP

Rediff.com5 Mar 2023

Singh's comment comes close on the heels of a large stockpile of drugs, cash and weapons being recovered near the Line of Control in Jammu and Kashmir's Poonch.

Pre-tariff rush to US lifts exports by 7% in July

Pre-tariff rush to US lifts exports by 7% in July

Rediff.com15 Aug 2025

India's goods exports rebounded in July after two months of contraction, with outbound shipments rising 7.3 per cent to $37.24 billion, led by a surge in exports to the United States before the country's reciprocal tariff kicked in and bolstered by a recovery in exports to other key markets.

CBI brings back 'meow meow' kingpin from UAE

CBI brings back 'meow meow' kingpin from UAE

Rediff.com11 Jul 2025

An alleged synthetic narcotics producer, Kubbawala Mustafa, wanted on an Interpol Red Notice, was deported to India from the UAE in an operation coordinated by the CBI and Mumbai police.

Andhra CM compares Jagan to 'drug lord Pablo Escobar'

Andhra CM compares Jagan to 'drug lord Pablo Escobar'

Rediff.com26 Jul 2024

Naidu claimed that he never saw such a situation like how it was when Reddy, the YSRCP chief, ruled during the past five years.

How US toughened trade terms with India

How US toughened trade terms with India

Rediff.com7 Aug 2025

From labelling India the 'Tariff King' to slapping sweeping import duties, US President Donald Trump has steadily hardened his trade stance on India. These announcements are being seen as a pressure tactic to get New Delhi to agree to demands made by the US in the proposed Bilateral Trade Agreement (BTA).

Trump Is Winning Tariff War Hands Down

Trump Is Winning Tariff War Hands Down

Rediff.com18 Aug 2025

Donald Trump's tariffs, meant as political punishment, have avoided the predicted chaos, lifting US growth, weakening rivals, and letting him claim victory in a resilient global economy, observes T T Ram Mohan.

Indian pharma firms not copying products of Swiss cos: Goyal

Indian pharma firms not copying products of Swiss cos: Goyal

Rediff.com10 Jun 2025

Dismissing allegations that Indian phacosrmaceutical companies copy products of Swiss firms, Commerce and Industry Minister Piyush Goyal on Tuesday said it is a long-standing myth and India respects intellectual property rights and never steals technology from others. He said that Swiss pharmaceutical companies have not shown even a single instance that Indian companies have illegally copied any of their trademarks or patents or copyrighted technology.

'While Others Experimented With Drugs, I Was In Love'

'While Others Experimented With Drugs, I Was In Love'

Rediff.com11 Oct 2024

When you are in love, you are preoccupied just with that.' 'Nothing else registers. It's like being drugged.'

States Seek Centre's Help To Deal With Trump's Tariffs

States Seek Centre's Help To Deal With Trump's Tariffs

Rediff.com2 Sep 2025

State governments have requested the Centre for export incentives, lifting of import duty in the case of cotton for the textile sector and GST exemptions.

India, US Push To Futureproof Trade Ties

India, US Push To Futureproof Trade Ties

Rediff.com29 Jul 2025

India is seeking either an exemption or a longer timeline on the pharmaceutical tariffs, expected to kick in by July 31.

Cipla Q4 profit up 30% at Rs 1,222 cr

Cipla Q4 profit up 30% at Rs 1,222 cr

Rediff.com14 May 2025

Drug major Cipla on Tuesday said its consolidated net profit increased 30 per cent to Rs 1,222 crore in the fourth quarter ended March 31, 2025. The Mumbai-based drug firm had reported a consolidated net profit of Rs 939 crore for the January-March period a year ago.

« Prev  |  Next »
Rediff
GET IT ONGoogle Play
GET IT ONApp Store
CONNECT
  • Rediffmail
  • Rediff One
  • - Rediffmail Enterprise
  • - Rediff Ecommerce
  • - Rediff HRMS
  • - Rediff CRM
  • - Rediff ERP
News
  • News
  • Business
  • Movies
  • Sports
  • Cricket
  • Get Ahead
  • Gurus
  • Astrology
  • Rediff Podcast
Stocks
  • BSE Live
  • NSE Live
  • Market News
  • Watchlist
  • Portfolio
Gurus
  • Health
  • Money
  • Career
  • Relationship
About Rediff|Advertise|Privacy Policy|Terms of Service|Investor Relations|Contact Us|© 2026 Rediff.com India Ltd. All rights reserved.